Author: Tom Wilemon
Potential second-line melanoma treatment identified
Aug. 15, 2019—A study led by Anna Vilgelm, MD, PhD, and Ann Richmond, PhD, has identified a possible second-line treatment for melanoma patients.
Protein’s role in inflammation-related cancer studied
Aug. 15, 2019—Investigators are exploring the molecular mechanisms behind the association of chronic inflammation and colon cancer.
Colorectal cancer patients warn against dismissing early symptoms
Aug. 7, 2019—Younger patients say colorectal cancer is a disease that doesn’t follow age guidelines, so pay attention to early symptoms.
Shu, Zheng receive Vietnam’s top honor for foreign scientists
Aug. 1, 2019—The Vietnamese Ministry of Health has awarded two Vanderbilt epidemiologists the Memorabilia Medal “For the People’s Health” in appreciation for their contributions in helping the nation establish a population-based research program for cancer, diabetes and other non-communicable diseases.
Grant bolsters research on myelodysplastic syndromes
Aug. 1, 2019—Michael Savona, MD, has received a competitive grant to develop therapies for patients with myelodysplastic syndromes.
Encephalitis identified as rare toxicity of immunotherapy treatment
Jul. 22, 2019—Researchers are chronicling rare but serious toxicities that may occur with immune checkpoint inhibitors, the most widely prescribed class of immunotherapies.
Hooker to lead National Society of Genetic Counselors
Jul. 18, 2019—Gillian Hooker, PhD, ScM, president-elect of the National Society of Genetic Counselors, will lead the organization at a pivotal time when she takes over as president Jan. 1, 2020.
Center for Immunobiology grows, bolsters program
Jul. 18, 2019—The Vanderbilt Center for Immunobiology has relaunched its mission with a greater focus on human immunology, an endeavor supported by additional researchers, more funding support and designation as a Center of Excellence.
Health disparity for blacks exists within lung screening guidelines
Jun. 27, 2019— by Tom Wilemon The U.S. Preventive Services Task Force (USPSTF) guidelines that determine which smokers qualify for CT scans exclude significant numbers of African Americans who develop lung cancer, a health disparity that merits modifications to lung cancer screening criteria, according to a study from Vanderbilt researchers. “Among smokers diagnosed with lung cancer, 32%...
Biomarkers of DNA methylation can be a predictor of breast cancer risk
Jun. 26, 2019—Biomarkers of DNA methylation, which regulate gene expression, can be a predictor of breast cancer risk.
Study identifies critical regulator of tumor-specific T cell differentiation
Jun. 18, 2019—A study published June 17 in Nature offers clues as to why blocking inhibitory receptors on tumor-infiltrating T cells may not always work
Cardiac toxicity risk factors identified with relapsed multiple myeloma therapy
Jun. 13, 2019—More than half of patients with relapsed multiple myeloma treated with carfilzomib experienced cardiac issues during treatment, according to a multi-institutional study published June 12 in the Journal of Clinical Oncology.
